» Articles » PMID: 15510745

The Management of Secondary Glaucoma in Nanophthalmic Patients

Overview
Journal Yan Ke Xue Bao
Specialty Ophthalmology
Date 2004 Oct 30
PMID 15510745
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate the clinical characteristcs, management of secondary glaucoma in nanophthalmos, and the prevention of its complications.

Methods: Retrospectively, 9 cases (17 eyes) with nanophthalmic glaucoma were studied.

Results: The axial length of the eyes ranged (14.36 - 19.33) mm; All of the cases combined with hyperopia ranged (+7.00 +/- 16.00) D. All 17 eyes had the manifestation like angle-closure glaucoma. The glaucoma was controlled in 9 of 17 eyes at the early stage, which underwent laser iridotomy (4 of 9 eyes also underwent laser iridoplasty). 1 eye underwent ciliary photocoagulation because its visual acuity was lost and the patient complained of pain. The other 7 eyes underwent filtration surgery and 3 of them had permanent loss of vision caused by disastrous complications after the surgery.

Conclusions: Management of secondary glaucoma in nanophthalmos is complicated. The laser iris surgery is safe and effective in glaucoma at the early stage. Vortex vein decompression, sclerotectomy or anterior sclerotomy may be performed to reduce disastrous complications.

Citing Articles

The Pathogenesis and Treatment of Complications in Nanophthalmos.

Yang N, Jin S, Ma L, Liu J, Shan C, Zhao J J Ophthalmol. 2020; 2020:6578750.

PMID: 32765903 PMC: 7387986. DOI: 10.1155/2020/6578750.


Membrane frizzled-related protein gene-related ophthalmological syndrome: 30-month follow-up of a sporadic case and review of genotype-phenotype correlation in the literature.

Neri A, Leaci R, Zenteno J, Casubolo C, Delfini E, Macaluso C Mol Vis. 2012; 18:2623-32.

PMID: 23112574 PMC: 3482175.


Glaucoma in a patient with nanophthalmos.

Nouri-Mahdavi K, Nilforushan N, Razeghinejad M, Amini H, Perera S J Ophthalmic Vis Res. 2012; 6(3):208-14.

PMID: 22454738 PMC: 3306100.